According to a study in the New England Journal of Medicine, administering a neuromuscular blocking agent for 48 hours at the onset of severe Adult Respiratory Distress Syndrome (ARDS) improved patient survival at 90 days without worsening muscle weakness. Read more here.
Is your Nursing Team an All-Pro Nursing Team? The deadline to enter the 2026 All-Pro Nursing Awards is Monday, March 9th 2026. We want to know how your team has made a difference. Apply now! Also check out last year's winners.
Giving a neuromuscular blocking agent early in ARDS may improve survival
Share

















